Study of the Protective Effect of Livergol against Liver Toxicity Caused by Bromobenzene in Mice Hepatoprotective effect of livergol
Iranian Journal of Pharmaceutical Sciences,
Vol. 10 Núm. 2 (2014),
1 abril 2014
,
Página 11-20
https://doi.org/10.22037/ijps.v10.40821
Resumen
Liver is a major organ of the body which can be exposed to various chemicals, drugs, and many other xenobiotics such as bromobenzene. Bromobenzene must be converted to its active metabolites to produce liver and kidney toxicity. Livergol is an herbal product which contains silymarin. The objective of this study was to find out the protective effect of livergol against liver toxicity induced by bromobenzene in mice. In this study, doses: 50, 100, 200, 300 mg/kg of livergol were administrated to mice orally 2 hours after bromobenzene(460 mg/kg) administration for 7 days (test groups). The negative control group received normal saline. The positive control group received 460 mg/kg of bromobenzene orally. 24 hours after the last administration animals were sacrificed; their blood was collected to determine serum enzyme activities of aspartate aminotransferase (AST) , alanine aminotransferase (ALT) and alkaline phosphatase (ALP). The livers were removed for histological examination.The results showed that livergol at doses 200 and 300 mg/kg cause significant reduction in the level of enzymes (p > 0.05). The histopathological study of liver tissues showed that doses of 200 and 300 mg/kg are more effectively restore tissue damage to the normal state. Our finding indicated that livergol in the high doses (200 and 300 mg/kg) have protective effects and cause significant improvement in the liver tissue and biochemical markers in bromobenzene intoxicated mice.
- bromobenzene
- hepatoprotective
- hepatotoxicity
- liver
- livergol
- mice.
Cómo citar
Citas
[2] Gurib-Fakim A. Medicinal plants: traditions of yesterday and drugs of tomorrow. Molecular aspects of Medicine (2006) 27(1):1-93.
[3] Karimi G, Vahabzadeh M, Lari P, Rashedinia M, Moshiri M. Silymarin, a Promising Pharmacological Agent for Treatment of Diseases* Iranian Journal of Basic Medical Sciences (2011) 14(4):308-17.
[4] Pradhan SC, Girish C. Hepatoprotective herbal drug, silymarin from experimental pharmacology to clinical medicine. Indian J Med Res (2006) 124:491-504.
[5] Dermarderosin A. The review of natural products. 1st ed. United States of America: Facts and Comparisions; (2001).
[6] Graf TN, Wani MC, Agarwal R, Kroll DJ, Oberlies NH. Gram-scale purification of flavonolignan diastereoisomers from Silybum marianum (Milk Thistle) extract in support of preclinical in vivo studies for prostate cancer chemoprevention. Planta Medica (2007) 73:1495-501.
[7] Kaur M, Agarwal R. Silymarin and epithelial cancer chemoprevention: how close we are to bedside? Toxicology and applied pharmacology (2007) 224(3):350-9.
[8] Chan K, Jensen Ns, Silber Pm, O’brien Pj. Structure-activity relationships for halobenzene induced cytotoxicity in rat and human hepatoctyes. Chem Biol Interacti (2007) 165:165-74.
[9] Bruchajzer E, Szymanska JA, Piotrowski JK. Acute and subacute nephrotoxicity of 2-bromophenol in rats. Toxicology letters (2002) 134(1):245-52.
[10] Zurita JL, Jos An, Peso Ad, Salguero M, Lopez-Artguez M, Repetto G. Ecotoxicological assessment of bromobenzene using a test battery with five model systems. Food and Chemical Toxicology (2007) 45:575-84.
[11] El-Sharaky AS, Newairy AA, Kamel MA, Eweda SM. Protective effect of ginger extract against bromobenzene-induced hepatotoxicity in male rats. Food Chem Toxicol ( 2009) 47:1584-90.
[12] Reitman S, Frankel S. A colorimetric method for the determination of serum levels of glutamic oxaloacetic acid and pyruvic acid transaminases. Am J Clin Pathol (1957) 10:394-9.
[13] King J. The phosphohydrolases and alkaline phosphatases. Practical clinical enzymology Van Nostrand Company limited: London (1965).
[14] forouzandeh h, azemi me, rashidi i, goudarzi m, kalantari h. study of the protective effect of teucrium polium L. extract on acetaminophen- induced hepatotoxicity in mice iranian journal of pharmaceutical research (2013) 12(1):123-9.
[15] Ahsan R, Islam KM, Musaddik A, Haque E. Hepatoprotective activity of methanol extract of some medicinal plants against carbon tetrachloride induced hepatotoxicity in albino rats. Global Journal of Pharmacology (2009) 3(3):116-22.
[16] A G, S L, O F. An overview of in vitro liver models. In: Animal Alternations Welfare and Ethics. 2ed ed.: Elsever Science BV: Amsterdam (1995).
[17] Gopi S, Setty O. Beneficial effect of the administration of Hemidesmus indicus against bromobenzene induced oxidative stress in rat liver mitochondria. Journal of ethnopharmacology 127(1):200-3.
[18] Wang BH, Zuzel KA, Rahman K, Billington D. Protective effects of aged garlic extract against bromobenzene toxicity to precision cut rat liver slices. Toxicology (1998) 126(3):213-22.
[19] Wong SG, Card JW, Racz WJ. The role of mitochondrial injury in bromobenzene and furosemide induced hepatotoxicity. Toxicology letters (2000) 116(3):171-81.
[20] Bhoopata L, Srichairatanakoob S, Kanjanapothic D. Hepatoprotective effects of lychee (Litchi chinensis Sonn.): A combination of antioxidant and anti-apoptotic activities. Journal of Ethnopharmacology (2011) 136:55-66.
[21] Madani H, Talebolhosseini M, Asgary S, Naderi GH. Hepatoprotective Activity of Silybum marianum and Cichorium intybus Against Thioacetamide in Rat. Pakistan Journal of Nutrition (2008) 7(1):172-6.
[22] Wu J-W, Lin L-C, Hung S-C, Lin C-H, Chi C-W, Tsai aT-H. Hepatobiliary Excretion of Silibinin in Normal and Liver Cirrhotic Rats. American Society for Pharmacology and Experimental Therapeutics (2008) 36(3):589-96.
[23] Vermeulen NPE, Bessems JGM, Straat Rvd. Molecularaspects of paracetamol-induced hepatotoxicity and its mechanism-based prevention. Drug Metab Rev (1992) 24 367-407.
[24] Jagadeesan G, Kavitha AV. Recovery of phosphatase and transaminase activity of mercury intoxicated Mus musculus (Linn.) liver tissue by Tribulus terrestris (Linn.) (Zygophyllaceae) extract. Tropical Biomedicine (2006) 23(1):45-51.
[25] El-Kamary1 SS, Shardell MD, Abdel-Hamid M, Ismail S, El-Ateek M, Metwally M, et al. A Randomized Controlled Trial to Assess the Safety and Efficacy of Silymarin on Symptoms, Signs and Biomarkers of Acute Hepatitis. Phytomedicine (2009) 16(5):391-400.
[26] Boigk G, Stroedter L, Herbst H, Waldschmidt J, Riecken EO, Schuppan D. Silymarin retards collagen accumulation in early and advanced biliary fibrosis secondary to complete bile duct obliteration in
rats. Hepatology (1997) 26:643-9.
[27] Hamed M, El-Rigal N, Ali S. Effects of Black seed oil on resolution of hepato renal toxicity induced by bromobenzene in rats. European review for medical and pharmacological sciences 17(5):569-81.
[28] Madani H, Talebolhosseini M, Asgary S, Naderi GH. Hepatoprotective Activity of Silybum marianum and Cichorium intybus Against Thioacetamide in Rat. Pakistan Journal of Nutrition (2008) 7(1):172-6.
[29] WenWu J, Lin L, Tsai TJ. Drug-drug interactions of silymarin on the perspective of pharmacokinetics. Ethnopharmacol (2009) 121:185-93.
[30] Ramakrishnan G, Muzio LL, Elinos-Baez CM, Jagan S, Augustine TA, Kamaraj S. Silymarin inhibited proliferation and induced apoptosis in hepatic cancer cells. Cell Prolif (2009) 42:229-40.
- Resumen ##plugins.themes.ojsPlusA.frontend.article.viewed##: 78 ##plugins.themes.ojsPlusA.frontend.article.times##
- IJPS_Volume 10_Issue 2_Pages 11-20 (English) ##plugins.themes.ojsPlusA.frontend.article.downloaded##: 48 ##plugins.themes.ojsPlusA.frontend.article.times##